Modern Care Journal

Published by: Kowsar

The Prevalence of Occult HBV Infection Among Hemodialysis Patients of Tehran, Iran

Mitra Ranjbar 1 , Masoumeh Dadkhah 2 , Farah Bokharaei Salim 3 , Marzieh Daneshbodi 2 , * , Shokoufeh Savaj 4 and Hossein Keyvani 3
Authors Information
1 Department of Infectious Disease, Iran University of Medical Sciences, Tehran, Iran
2 Departmant of Internal Medicine, Firuozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
3 Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4 Department of Nepgrology, Firuozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Modern Care Journal: October 2017, 14 (4); e65546
  • Published Online: October 31, 2017
  • Article Type: Research Article
  • Received: August 28, 2017
  • Revised: September 28, 2017
  • Accepted: October 25, 2017
  • DOI: 10.5812/modernc.65546

To Cite: Ranjbar M, Dadkhah M, Bokharaei Salim F, Daneshbodi M, Savaj S, et al. The Prevalence of Occult HBV Infection Among Hemodialysis Patients of Tehran, Iran, Mod Care J. 2017 ; 14(4):e65546. doi: 10.5812/modernc.65546.

Copyright © 2017, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Arababadi MK, Nasiri Ahmadabadi B, Yousefi Daredor H, Kennedy D. Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients. Hepat Mon. 2012;12(5):315-9. doi: 10.5812/hepatmon.5934. [PubMed: 22783342].
  • 2. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol. 2007;13(43):5682-6. [PubMed: 17963292].
  • 3. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009;51(3):581-92. doi: 10.1016/j.jhep.2009.05.022. [PubMed: 19616338].
  • 4. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010;17(1):1-15. doi: 10.1111/j.1365-2893.2009.01245.x. [PubMed: 20002296].
  • 5. Urbani S, Fagnoni F, Missale G, Franchini M. The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med. 2010;48(1):23-9.
  • 6. Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol Rev. 2000;174:98-111. [PubMed: 10807510].
  • 7. Gutierrez-Garcia ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, Buhigas-Garcia I. Prevalence of occult hepatitis B virus infection. World J Gastroenterol. 2011;17(12):1538-42. doi: 10.3748/wjg.v17.i12. [PubMed: 21472117].
  • 8. Tajik Z, Keyvani H, Bokharaei-Salim F, Zolfaghari MR, Fakhim S, Keshvari M, et al. Detection of Hepatitis B Virus Covalently Closed Circular DNA in the Plasma of Iranian HBeAg-Negative Patients With Chronic Hepatitis B. Hepat Mon. 2015;15(9). e30790. doi: 10.5812/hepatmon.30790. [PubMed: 26504471].
  • 9. Keyvani H, Taghinezhad Saroukalaei S, Mohseni AH. Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients. Jundishapur J Microbiol. 2016;9(5). e31733. doi: 10.5812/jjm.31733. [PubMed: 27540455].
  • 10. Zobeiri M. Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat. 2013;2013.
  • 11. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci. 2009;14(4):249-58. [PubMed: 21772891].
  • 12. Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, et al. Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon. 2015;7(1). e22674. doi: 10.5812/numonthly.22674. [PubMed: 25738121].
  • 13. Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial. 2010;14(3):349-53. doi: 10.1111/j.1744-9987.2009.00798.x. [PubMed: 20609190].
  • 14. Ayatollahi J, Jahanabadi S, Sharifyazdi M, Hemayati R, Vakili M, Shahcheraghi SH. The Prevalence of Occult Hepatitis B Virus in the Hemodialysis Patients in Yazd, Iran. Acta Medica Iranica. 2017;54(12):784-7.
  • 15. Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012;12(4):253-8. doi: 10.5812/hepatmon.665. [PubMed: 22690232].
  • 16. Cabrerizo M, Bartolome J, De Sequera P, Caramelo C, Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol. 1997;8(9):1443-7. [PubMed: 9294837].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments